302092

Validity of procalcitonin as diagnostic biomarker for infective endocarditis

Article

Last updated: 04 Jan 2025

Subjects

-

Tags

Disease markers.
Infection and immunity.

Abstract

Background: Infective endocarditis (IE) is still a fatal infection with high morbidity and mortality. Successful patient outcomes depend on prompt diagnosis and effective therapy. Blood cultures are usually time consuming and sometimes echocardiography is falsely negative. Thus, a straightforward blood test may assist early diagnosis of IE. Multiple studies have revealed that procalcitonin (PCT) was highly associated with bacteremia - the main diagnostic criteria for endocarditis - in patients with fever.
Objectives: We aimed to assess the diagnostic significance of procalcitonin concentration in suspected patients of IE.
Patients and methods:  Twenty-two patients admitted to Assiut University Heart Hospital with a suspicion of IE were enrolled in a prospective study. Based on clinical, microbiological, and echocardiographic findings, Modified duke criteria were applied to the cases to confirm their diagnosis as definite, possible, or rejected IE cases before testing for procalcitonin was done. The study also included fifteen healthy volunteers for comparison with IE patients.
Results: Procalcitonin was significantly higher (P-value <0.05) in patients diagnosed as definite and possible IE than with healthy volunteers. The area under the ROC curve was 0.705. At cutoff value of 0.425 ng/ml, the procalcitonin test's sensitivity, specificity, negative predictive value, and positive predictive values were 47.6%, 93.3%, 56%, and 90.9%, respectively.
Conclusion: This study implies that procalcitonin may be a valuable supplementary diagnostic marker in IE diagnosis.  A threshold value of 0.425 ng/ml should be used for ruling out endocarditis in routine clinical practice and the diagnosis of IE can be strongly excluded below this value.

DOI

10.21608/svuijm.2023.212553.1589

Keywords

Procalcitonin, Infective endocarditis, Duke criteria

Authors

First Name

Momen M.

Last Name

Thabet

MiddleName

-

Affiliation

Department of Microbiology and Immunology, Faculty of Pharmacy, South Valley University, Qena, Egypt.

Email

pharmacistmomen@gmail.com

City

-

Orcid

0000-0002-0523-8443

First Name

Marwan S.

Last Name

Mahmoud

MiddleName

-

Affiliation

Department of Cardiology, Assiut University Heart Hospital, Assiut University, Assiut, Egypt.

Email

marwancordio@aun.edu.eg

City

-

Orcid

-

First Name

Ayman Khairy Mohamed

Last Name

Hassan

MiddleName

-

Affiliation

Department of Cardiology, Assiut University Heart Hospital, Assiut University, Assiut, Egypt.

Email

ayman.hassan@aun.edu.eg

City

-

Orcid

-

First Name

Ehsan A.

Last Name

Hassan

MiddleName

-

Affiliation

Department of Medical Microbiology and Immunology, Faculty of Medicine, Assiut University, Assiut, Egypt.

Email

dr_ehsan66@aun.edu.eg

City

-

Orcid

-

First Name

Khaled

Last Name

Hassanein

MiddleName

Mohamed

Affiliation

Department of Medical Microbiology and Immunology, Faculty of Medicine, Assiut University, Assiut, Egypt.

Email

khaledhassanein70@aun.edu.eg

City

-

Orcid

-

First Name

Mona Hussein

Last Name

Abdel-Rahim

MiddleName

-

Affiliation

Department of Medical Microbiology and Immunology, Faculty of Medicine, Assiut University, Assiut, Egypt.

Email

mona.hussein@aun.edu.eg

City

-

Orcid

-

Volume

6

Article Issue

2

Related Issue

40200

Issue Date

2023-07-01

Receive Date

2023-04-22

Publish Date

2023-07-01

Page Start

347

Page End

352

Print ISSN

2735-427X

Online ISSN

2636-3402

Link

https://svuijm.journals.ekb.eg/article_302092.html

Detail API

https://svuijm.journals.ekb.eg/service?article_code=302092

Order

32

Type

Original research articles

Type Code

1,520

Publication Type

Journal

Publication Title

SVU-International Journal of Medical Sciences

Publication Link

https://svuijm.journals.ekb.eg/

MainTitle

Validity of procalcitonin as diagnostic biomarker for infective endocarditis

Details

Type

Article

Created At

27 Dec 2024